找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Bispecific Antibodies; Roland E. Kontermann Book 2011 Springer-Verlag Berlin Heidelberg 2011 Cancer therapy.Hybridoma.Immunoglobulin.Immun

[復(fù)制鏈接]
查看: 55797|回復(fù): 61
樓主
發(fā)表于 2025-3-21 20:08:53 | 只看該作者 |倒序瀏覽 |閱讀模式
期刊全稱Bispecific Antibodies
影響因子2023Roland E. Kontermann
視頻videohttp://file.papertrans.cn/189/188886/188886.mp4
發(fā)行地址Presents the recent advances in antibody engineering and in the various clinical applications.An invaluable resource for both experts and those new to the field.With contributions by international exp
圖書封面Titlebook: Bispecific Antibodies;  Roland E. Kontermann Book 2011 Springer-Verlag Berlin Heidelberg 2011 Cancer therapy.Hybridoma.Immunoglobulin.Immun
影響因子.The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications were established, such as pre-targeting strategies in radioimmunotherapy and dual targeting approaches in order to improve binding, selectivity and efficacy..In this book, the different ways of generating bispecific antibodies are described, with emphasis on recombinant formats. The various applications of bispecific antibodies, e.g. in cellular cancer immunotherapy, radioimmunotherapy and pretargeting strategies are covered, and emerging applications such as dual targeting strategies, which involve the simultaneous inhibition of two targets, are addressed..
Pindex Book 2011
The information of publication is updating

書目名稱Bispecific Antibodies影響因子(影響力)




書目名稱Bispecific Antibodies影響因子(影響力)學(xué)科排名




書目名稱Bispecific Antibodies網(wǎng)絡(luò)公開度




書目名稱Bispecific Antibodies網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Bispecific Antibodies被引頻次




書目名稱Bispecific Antibodies被引頻次學(xué)科排名




書目名稱Bispecific Antibodies年度引用




書目名稱Bispecific Antibodies年度引用學(xué)科排名




書目名稱Bispecific Antibodies讀者反饋




書目名稱Bispecific Antibodies讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:45:12 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:55:10 | 只看該作者
,Allgemeine physikalische Hilfss?tze,ill present an overview of work that have been published, including a brief introduction to the particular molecular scaffolds with the structural basis and some of the biophysical and biochemical properties before describing the bispecific application.
地板
發(fā)表于 2025-3-22 07:44:54 | 只看該作者
Die Technik der kystoskopischen Untersuchunghe biochemical and biophysical properties and the manufacturability of BsAb. This chapter reviews the current advances in design and engineering of the IgG-like BsAb in the context of their potential clinical applications.
5#
發(fā)表于 2025-3-22 10:36:46 | 只看該作者
6#
發(fā)表于 2025-3-22 14:10:46 | 只看該作者
Alternative Scaffolds as Bispecific Antibody Mimetics,ill present an overview of work that have been published, including a brief introduction to the particular molecular scaffolds with the structural basis and some of the biophysical and biochemical properties before describing the bispecific application.
7#
發(fā)表于 2025-3-22 20:43:37 | 只看該作者
The Design and Engineering of IgG-Like Bispecific Antibodies,he biochemical and biophysical properties and the manufacturability of BsAb. This chapter reviews the current advances in design and engineering of the IgG-like BsAb in the context of their potential clinical applications.
8#
發(fā)表于 2025-3-22 21:18:57 | 只看該作者
The Dock-and-Lock (DNL) Approach to Novel Bispecific Antibodies, AD module occurs spontaneously, and the resulting complex is locked with disulfide bonds to enhance in vivo stability. This new platform technology provides a versatile approach to create novel bispecific antibodies of multiple valencies, with potential applications in the detection and therapy of diverse diseases.
9#
發(fā)表于 2025-3-23 02:31:29 | 只看該作者
10#
發(fā)表于 2025-3-23 07:28:36 | 只看該作者
ose new to the field.With contributions by international exp.The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 07:33
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
阿瓦提县| 赤峰市| 通许县| 略阳县| 古交市| 平凉市| 宁国市| 滦南县| 宁明县| 绥德县| 西宁市| 河西区| 金山区| 嘉定区| 开平市| 浦北县| 奎屯市| 永顺县| 诏安县| 周口市| 泰州市| 漳浦县| 台北县| 黄骅市| 安康市| 盐源县| 边坝县| 太白县| 石城县| 宜兴市| 新密市| 尖扎县| 黎川县| 汉中市| 伊宁县| 庆城县| 秦安县| 法库县| 陆丰市| 通山县| 湖口县|